Hermansen JU, Kong W, Brodersen AM, Yin Y, Urban A, Rein ID, He L, Agius R, Teglgaard RS, Rousu J, Brieghel C, Kersting S, Levin MD, Tran HTT, Mattsson M, Ranti J, Veldhuis GJ, da Cunha-Bang C, Mous R, Dubois J, Kater AP, Enserink JM, Niemann CU, Aittokallio T, Skånland SS (2026)
A functional prognostic model predicts progression-free survival in patients with relapsed chronic lymphocytic leukemia treated with ibrutinib + venetoclax
Hemasphere, 10 (9), e70467
DOI 10.1002/hem3.70467, PubMed 42757031

Ullern H, Johannessen JA, Kasikci F, Formica M, Karimi Melve N, Andresen S, Brech A, Axcrona K, Jørgensen K, Farkas L, Enserink JM, Knævelsrud H (2026)
FLCN loss is characterized by SQSTM1/p62 accumulation despite functional autophagy flux in Birt-Hogg-Dubé syndrome-associated kidney cancer
Autophagy Rep, 5 (1), 2705631
DOI 10.1080/27694127.2026.2705631, PubMed 42569319

Willoch-Allen K, Zhao Z, Ayuda-Durán P, Mikaeloff F, Struyf N, Österroos A, Lehmann S, Kallioniemi O, Saarela J, Tyner JW, Erkers T, Enserink JM, Aittokallio T (2026)
A multi-center study on the consistency of drug sensitivity testing in patients with acute myeloid leukemia
NPJ Precis Oncol, 10 (1)
DOI 10.1038/s41698-026-01480-4, PubMed 42135420